Cost Effectiveness of Pertussis Vaccination in Adults
- 1 March 2007
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 32 (3) , 186-193.e2
- https://doi.org/10.1016/j.amepre.2006.10.016
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Pertussis in Adolescents and Adults: Should We Vaccinate?Published by American Academy of Pediatrics (AAP) ,2005
- Societal Costs and Morbidity of Pertussis in Adolescents and AdultsClinical Infectious Diseases, 2004
- Adolescent and adult pertussis vaccination: computer simulations of five new strategiesVaccine, 2004
- Evaluation of Strategies for Use of Acellular Pertussis Vaccine in Adolescents and Adults: A Cost-Benefit AnalysisClinical Infectious Diseases, 2004
- Severe and unrecognised: pertussis in UK infantsArchives of Disease in Childhood, 2003
- Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoidsThe Pediatric Infectious Disease Journal, 2002
- The Increasing Incidence of Pertussis in Massachusetts Adolescents and Adults, 1989–1998The Journal of Infectious Diseases, 2000
- A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adultsVaccine, 2000
- The Seroepidemiology of Bordetella pertussis Infections: A Study of Persons Ages 1-65 YearsThe Journal of Infectious Diseases, 1996
- Symptoms and complications of pertussis in adultsInfection, 1995